Current Evidence on Therapeutic Approaches to BCBM: Local Therapy and HER2-Positive Disease

Download this slideset for an expert-curated overview of the latest clinical data informing optimal local management of breast cancer brain metastases along with a review of the evolving role for systemic therapy in the treatment of HER2-positive CNS disease.
Lee Schwartzberg, MD, FACP
Format: Microsoft PowerPoint (.ppt)
File Size: 1.38 MB
Released: December 10, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Genentech, a member of the Roche Group
Puma Biotechnology, Inc.

Related Content

Expert review and discussion of key data from SABCS 2020 in HER2-positive and hormone receptor–positive/HER2-negative disease, and metastatic triple-negative breast cancer from Clinical Care Options (CCO)

Sara Hurvitz, MD, FACP Joyce O'Shaughnessy, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: February 19, 2021 Expired: February 18, 2022

Download this short summary slideset oncurrent treatment for patients with HER2-positive breast cancer, from NCCN and Clinical Care Options (CCO).

Jame Abraham, MD, FACP Hope S. Rugo, MD Sara Tolaney, MD, MPH Released: February 9, 2021

Download these expert-selected slides on treating patients with HER2-positive metastatic breast cancer, from NCCN and Clinical Care Options (CCO).

Hope S. Rugo, MD Released: February 3, 2021

Download these expert-selected slides on treatment for patients with HER2-positive early breast cancer, from NCCN and Clinical Care Options (CCO).

Jame Abraham, MD, FACP Released: February 2, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue